Rallybio (RLYB) Equity Average (2023 - 2026)
Rallybio's Equity Average history spans 3 years, with the latest figure at $60.5 million for Q4 2025.
- On a quarterly basis, Equity Average fell 8.67% to $60.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.5 million, a 8.67% decrease, with the full-year FY2025 number at $59.8 million, down 28.73% from a year prior.
- Equity Average hit $60.5 million in Q4 2025 for Rallybio, up from $54.5 million in the prior quarter.
- Over the last five years, Equity Average for RLYB hit a ceiling of $162.3 million in Q1 2023 and a floor of $50.0 million in Q2 2025.
- Historically, Equity Average has averaged $91.9 million across 3 years, with a median of $80.0 million in 2024.
- Biggest five-year swings in Equity Average: tumbled 42.61% in 2024 and later fell 8.67% in 2025.
- Tracing RLYB's Equity Average over 3 years: stood at $114.9 million in 2023, then tumbled by 42.34% to $66.2 million in 2024, then decreased by 8.67% to $60.5 million in 2025.
- Business Quant data shows Equity Average for RLYB at $60.5 million in Q4 2025, $54.5 million in Q3 2025, and $50.0 million in Q2 2025.